Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/6/2025

Osteoporosis Management in Elderly Patients

Introduction to Osteoporosis Treatment

  • The American College of Rheumatology recommends an orthogeriatric multidisciplinary approach for patients in their late 80s or older with osteoporosis, including oral bisphosphonates, calcium, and vitamin D supplementation, as well as fall prevention strategies 1, 2, 3

Multidisciplinary Orthogeriatric Approach

  • Frail elderly patients with major fractures require orthogeriatric co-management, including comprehensive geriatric assessment, to reduce inpatient and 1-year mortality rates 1, 4
  • Structured collaboration between healthcare workers is mandatory to provide optimal care through coordinated services 1, 2
  • Optimal care in preoperative, operative, and postoperative phases directly affects clinical outcomes, with limited mobility and poor quality of life postoperatively associated with elevated risk of future fractures 1, 2

Risk Assessment and Fracture Prevention

  • All patients aged 50 and over with a recent fracture should be evaluated systematically for subsequent fracture risk, including review of clinical risk factors and DXA of spine and hip 4, 3
  • For elderly patients with immobility and comorbidities, anti-osteoporotic treatment can be started even without a DXA scan if they do not respond to invitations for fracture liaison services 1
  • FRAX may underestimate risk in very elderly patients with multiple falls or frailty, so clinical judgment is essential in this population 3

Pharmacological Treatment Algorithm

  • Oral bisphosphonates, such as alendronate or risedronate, are first-choice agents due to their efficacy, low cost, and extensive clinical experience 2, 6, 3, 5
  • Treatment duration is typically 3-5 years, and longer in patients who remain at high risk 2, 6
  • For patients with oral intolerance, dementia, malabsorption, or non-compliance, zoledronic acid or denosumab are appropriate alternatives 2, 6, 3, 5

Mandatory Concurrent Non-Pharmacological Treatment

  • Calcium supplementation of 1,000-1,200 mg elemental calcium daily is required, along with vitamin D supplementation of 800 IU daily to maintain serum 25(OH)D levels ≥30 ng/mL 2, 6, 3, 5
  • High pulse dosages of vitamin D are associated with increased fall risk and should be avoided 2, 6

Rehabilitation and Fall Prevention

  • An appropriate rehabilitation program should include early postfracture physical training, muscle strengthening, and long-term continuation of balance training and multidimensional fall prevention 4, 3
  • Regular weight-bearing exercises, resistance training, and balance exercises are recommended for all patients over 80 3, 5

Monitoring and Follow-Up

  • Regular monitoring for medication tolerance and adherence is essential, as long-term adherence to drug treatment is poor without systematic follow-up 2, 6, 3, 5
  • Clinical fracture risk reassessment should be performed every 12 months, with BMD testing every 1-3 years depending on risk factors 3, 5
  • Adherence to therapy is substantially higher in fracture liaison services, where patients are more motivated after their recent fracture 2, 6
  • Patient education about disease burden, risk factors, follow-up, and duration of therapy is critical for adherence 4, 3, 5